The week in health tech, explained in plain English.Get the free newsletter →
October 25, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

Medical School Graduates Per Capita Vary Widely by State

States differ sharply in how many medical school graduates they produce relative to population, according to a new analysis from Becker's Hospital Review. The publication calculated graduates per 100,000 residents using 2025 U.S. Census Bureau population estimates alongside 2024 graduate counts from the Association of American Medical Colleges, compiled by KFF.

The key caveat: these numbers show where physicians are trained, not where they practice. A state can graduate large medical school classes and still face physician shortages if those graduates leave for residencies and jobs elsewhere. Residency capacity, local job markets, and reimbursement all shape where new doctors ultimately settle.

For hospital and health system leaders, the data is a reminder that workforce planning cannot rely on graduate output alone. Retaining trained physicians, expanding graduate medical education slots, and building pipelines from training to practice matter more than raw class sizes. As staffing pressures persist nationwide, understanding the gap between training and practice is central to addressing local physician supply.

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.